Isoniazid Preventive Therapy
Isoniazid Preventive Therapy, also known as IPT, is a prevalent preventive care measure in the field of medicine. IPT is a medication that is used to prevent the spread of tuberculosis (TB) bacteria from the infected person to those who have not been infected. It is a crucial preventive measure for people who are at risk of developing latent TB infection or active tuberculosis. IPT is mainly recommended for individuals who are infected with HIV, as people living with HIV are more susceptible to TB infection. When they acquire TB infection, it is more likely to progress faster into active TB than in those without HIV. IPT has been shown to significantly reduce the likelihood of TB infection in people living with HIV and also reduce the risk of developing active TB. The drug is taken orally, and it is recommended to be taken under direct observation to ensure adherence to the routine. The medication should be taken every day for a period of six to nine months, depending on the recommendation of the healthcare provider. IPT also provides a cost-effective way of preventing the spread of TB in the community. By reducing the transmission of TB, the need for expensive and complex treatments is reduced, and the quality of life of infected individuals is enhanced. In conclusion, IPT is an effective and essential preventive measure for individuals at risk of TB infection, particularly people living with HIV. It is a vital tool in the fight against TB and should be availed to those who are at risk of contracting TB. By taking IPT, individuals can protect themselves, their families, and the entire community from the spread of TB.
← Journal of Preventive Medicine And Care